Search Results 581-590 of 37090 for prostate cancer
Areas of focus include discovering new treatment options and strategies for metastatic castration-resistant prostate cancer (mCRPC). Researchers are translating ...
what the survivor might experience based on the type of cancer. For example, both prostate cancer and its treatment can cause urinary incontinence and erectile ...
Giving carboplatin with the standard of care chemotherapy drug cabazitaxel may be better at treating metastatic castrate-resistant prostate cancer.
Learn about this type of radiation therapy for prostate cancer that involves placing radioactive seeds or wires in the prostate gland.
Positron Emission Tomography Using 64Cu-SAR-bisPSMA In Participants With High-risk Prostate Cancer Prior To Radical Prostatectomy · Overview · Participation ...
... Prostate Cancer. Rochester, Minn. 99mTc-MIP-1404 is a radioactive diagnostic imaging agent indicated for imaging men with newly diagnosed prostate cancer ...
cancer, Breast cancer, Head and neck cancer, Prostate cancer, Bladder cancer, Testicular cancer. Show more areas of focus for Carlos E. Vargas, M.D.. Research.
Castration-resistant prostate cancer patients with rising prostatic specific antigen (PSA) are eligible for this study. 11C-Choline PET/CT will be used to ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!